Forced MyHCIIB expression following targeted genetic manipulation of conditionally immortalized muscle precursor cells.

The ability to carry out gene targeting in somatic stem cells while maintaining their stem cell characteristics would have important implications for gene therapy and for the analysis of gene function. Using mouse myoblasts, we have explored this possibility by attempting to alter the promoter of a myosin heavy chain gene (MyHCIIB) characteristic of physiologically "fast" muscle so as to force its unscheduled expression in physiologically "slow" muscle fibers. Conditionally immortalized muscle precursor cells were transfected with a gene targeting construct designed to replace the MyHCIIB promoter with that for the carbonic anhydrase III gene (CAIII), which is highly expressed in slow muscle. A potentially targeted clone was isolated and differentiated in culture to form myotubes which expressed MyHCIIB. Cells from the same clone were injected into both slow and fast muscle of host mice, where they contributed to fiber formation. In slow muscle, the fibers derived from this clone did not express MyHCIIB; this may reflect an instability of the targeted MyHCIIB locus and/or a failure of the hybrid promoter to function in slow fibers in vivo. Nonetheless, we have demonstrated that a "promoter knock-in" gene targeting procedure can be used to generate unique MyHCIIB-expressing myotubes in culture and that conditionally immortalized myoblasts can be subjected to extensive passaging and genetic manipulation without losing their ability to form fibers in culture and in vivo.

[1]  J. Morgan,et al.  Muscle precursor cells injected into irradiated mdx mouse muscle persist after serial injury , 1999, Muscle & nerve.

[2]  S. Salmons,et al.  The dose‐related response of rabbit fast muscle to long‐term low‐frequency stimulation , 1998, Muscle & nerve.

[3]  Nicolas Deconinck,et al.  Expression of full-length utrophin prevents muscular dystrophy in mdx mice , 1998, Nature Medicine.

[4]  A. Porter,et al.  Therapeutic gene targeting , 1998, Gene Therapy.

[5]  A. Porter Controlling your losses: conditional gene silencing in mammals. , 1998, Trends in Genetics.

[6]  C. Gilbert,et al.  Construction by gene targeting in human cells of a ‘conditional’ CDC2 mutant that rereplicates its DNA , 1997, Nature Genetics.

[7]  K. Davies,et al.  Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene , 1996, Nature.

[8]  K. Rajewsky,et al.  Conditional gene targeting. , 1996, The Journal of clinical investigation.

[9]  Joong Hwan Oh,et al.  Mechanisms of Dynamic Cardiomyoplasty: Current Concepts , 1996, Journal of cardiac surgery.

[10]  P. Schnegelsberg,et al.  Functional redundancy of the muscle-specific transcription factors Myf5 and myogenin , 1996, Nature.

[11]  F. Watt,et al.  Stem cell patterning and fate in human epidermis , 1995, Cell.

[12]  O. Smithies,et al.  Altering mice by homologous recombination using embryonic stem cells. , 1994, The Journal of biological chemistry.

[13]  M. Noble,et al.  Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines. , 1994, Developmental biology.

[14]  T. Dexter,et al.  Influence of growth factors and substrates on differentiation of haemopoietic stem cells. , 1993, Current opinion in cell biology.

[15]  K. Rajewsky,et al.  Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting , 1993, Cell.

[16]  T. Partridge,et al.  Long-term persistence and migration of myogenic cells injected into pre-irradiated muscles of mdx mice , 1993, Journal of the Neurological Sciences.

[17]  T. Vulliamy,et al.  Evolutionary conservation of the dystrophin central rod domain. , 1992, The Biochemical journal.

[18]  T. Partridge,et al.  Cell transplantation and gene therapy in muscular dystrophy. , 1992, BioEssays : news and reviews in molecular, cellular and developmental biology.

[19]  S. Takeda,et al.  A possible regulatory role for conserved promoter motifs in an adult-specific muscle myosin gene from mouse. , 1992, The Journal of biological chemistry.

[20]  F. Walsh,et al.  Formation of skeletal muscle in vivo from the mouse C2 cell line. , 1992, Journal of cell science.

[21]  A. Irintchev,et al.  Formation of new muscle fibres and tumours after injection of cultured myogenic cells , 1991, Journal of neurocytology.

[22]  Philippe Soriano,et al.  Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. , 1991, Genes & development.

[23]  M. Rudnicki,et al.  Simplified mammalian DNA isolation procedure. , 1991, Nucleic acids research.

[24]  D. Kioussis,et al.  Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Tweedie,et al.  CAIII a marker for early myogenesis: Analysis of expression in cultured myogenic cells , 1991, Somatic cell and molecular genetics.

[26]  Simon C Watkins,et al.  Somatic reversion/suppression of the mouse mdx phenotype in vivo , 1990, Journal of the Neurological Sciences.

[27]  M. Capecchi,et al.  Altering the genome by homologous recombination. , 1989, Science.

[28]  L. Kunkel,et al.  Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts , 1989, Nature.

[29]  H. Koren,et al.  Methods for Studying Mononuclear Phagocytes , 1981 .

[30]  D. Pette,et al.  Mammalian skeletal muscle fiber type transitions. , 1997, International review of cytology.

[31]  M. Arbonés,et al.  Gene targeting in normal somatic cells: inactivation of the interferon–γ receptor in myoblasts , 1994, Nature Genetics.

[32]  M. King,et al.  A rapid and efficient, nonradioactive method for screening recombinant DNA libraries. , 1994, BioTechniques.

[33]  G. Lyons,et al.  Carbonic anhydrase III, an early mesodermal marker, is expressed in embryonic mouse skeletal muscle and notochord. , 1991, Development.

[34]  D. Kioussis,et al.  H‐2Kb‐tsA58トランスジェニックマウスから直接に無限増殖細胞系を得る方法 , 1991 .

[35]  D. Pette,et al.  Cellular and molecular diversities of mammalian skeletal muscle fibers. , 1990, Reviews of physiology, biochemistry and pharmacology.